Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)
SEK 1.48
(0.68%)
SEK 1.48
(0.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.82 Million | 473 Thousand | 49 Thousand | 131 Thousand | 556 Thousand | 560 Thousand |
| Cost of Revenue | 1.16 Million | 528 Thousand | -274 Thousand | 145 Thousand | 227 Thousand | 258 Thousand |
| Gross Profit | 1.65 Million | -55 Thousand | 323 Thousand | -14 Thousand | 329 Thousand | 302 Thousand |
| Operating Expenses | 21.89 Million | 20.85 Million | 17.4 Million | 10.81 Million | 12.3 Million | 5.11 Million |
| Selling, General and Administrative Expenses | 19.11 Million | 17.86 Million | 16.95 Million | 6.66 Million | 11.72 Million | 6.64 Million |
| Research and Development Expenses | 2.57 Million | 2.9 Million | -2.53 Million | -1.28 Million | -4.1 Million | -3.85 Million |
| Other Expenses | 207 Thousand | 20.85 Million | 19.93 Million | 5.43 Million | 4.67 Million | 2.33 Million |
| Cost and Expenses | 23.05 Million | 21.38 Million | 17.12 Million | 10.96 Million | 12.52 Million | 5.37 Million |
| Operating Income | -20.13 Million | -20.91 Million | -17.07 Million | -10.82 Million | -11.97 Million | -4.81 Million |
| Interest Expense | 1.4 Million | 1.89 Million | 675 Thousand | 835 Thousand | 260 Thousand | 76 Thousand |
| Income Tax Expense | - | 1.83 Million | 675 Thousand | 835 Thousand | 260 Thousand | -20 Thousand |
| Earnings before Tax | -21.09 Million | -22.74 Million | -17.74 Million | -11.66 Million | -12.32 Million | -4.79 Million |
| Net Income | -21.09 Million | -24.58 Million | -18.41 Million | -12.49 Million | -12.58 Million | -4.79 Million |
| Earnings Per Share Basic | -1.13 | -2.47 | -2.13 | -2.54 | -3.06 | -1.47 |
| Earnings Per Share Diluted | -1.13 | -2.47 | -2.13 | -2.54 | -3.06 | -1.47 |
| Weighted Average Shares Outstanding | 18.6 Million | 9.96 Million | 8.65 Million | 4.92 Million | 4.11 Million | 3.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.6 Million | 9.96 Million | 8.65 Million | 4.92 Million | 4.11 Million | 3.26 Million |
| Gross Margin | 0.59 | -0.12 | 6.59 | -0.11 | 0.59 | 0.54 |
| EBIT Margin | -6.94 | -37.85 | -290.86 | -67.95 | -18.42 | -6.37 |
| Profit Margin | -7.47 | -51.97 | -375.88 | -95.41 | -22.63 | -8.57 |
| EBITDA | -19.57 Million | -20.8 Million | -17.02 Million | -10.77 Million | -12.01 Million | -8.03 Million |
| Earnings Before Tax Margin | -7.14 | -44.21 | -348.51 | -82.66 | -21.53 | -8.60 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.68 Million | 1.34 Million | 2.82 Million | 507 Thousand | 1.08 Million | 1.18 Million |
| Cost of Revenue | 5.42 Million | 4.14 Million | 22.96 Million | 5.8 Million | 5.07 Million | 7.13 Million |
| Gross Profit | -3.74 Million | -2.79 Million | -20.13 Million | -5.29 Million | -3.99 Million | -5.95 Million |
| Operating Expenses | 4.83 Million | 4.14 Million | 21.89 Million | 4.65 Million | 5.1 Million | 7.15 Million |
| Selling, General and Administrative Expenses | 4.31 Million | 1.33 Million | - | 1.49 Million | 1.51 Million | 1.62 Million |
| Research and Development Expenses | - | - | - | 2.57 Million | - | - |
| Other Expenses | 519 Thousand | - | - | - | - | - |
| Cost and Expenses | 5.42 Million | 4.14 Million | 22.96 Million | 5.8 Million | 5.1 Million | 7.15 Million |
| Operating Income | -3.74 Million | -2.79 Million | -20.13 Million | -5.29 Million | -4.02 Million | -5.97 Million |
| Interest Expense | - | - | 1.4 Million | - | 500 Thousand | 405 Thousand |
| Income Tax Expense | - | 458.72 Thousand | 2.51 Million | 462.18 Thousand | 746.58 Thousand | 610.91 Thousand |
| Earnings before Tax | -4.1 Million | -3.2 Million | -21.09 Million | -5.14 Million | -4.52 Million | -6.38 Million |
| Net Income | -4.1 Million | -3.2 Million | -21.09 Million | -5.14 Million | -4.52 Million | -6.38 Million |
| Earnings Per Share Basic | -0.18 | -0.18 | - | -0.35 | -0.33 | -0.48 |
| Earnings Per Share Diluted | -0.18 | -0.18 | - | -0.35 | -0.33 | -0.48 |
| Weighted Average Shares Outstanding | 23.34 Million | 17.93 Million | 13.48 Million | 14.74 Million | 13.85 Million | 13.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 23.34 Million | 17.93 Million | 13.48 Million | 14.74 Million | 13.85 Million | 13.27 Million |
| Gross Margin | -2.22 | -2.08 | -7.14 | -10.45 | -3.70 | -5.04 |
| EBIT Margin | -1.93 | -1.71 | - | -9.45 | -3.07 | -4.44 |
| Profit Margin | -2.44 | -2.38 | -7.47 | -10.15 | -4.19 | -5.40 |
| EBITDA | -3.24 Million | -2.29 Million | - | -4.79 Million | -3.31 Million | -5.24 Million |
| Earnings Before Tax Margin | -2.22 | -2.08 | -7.14 | -10.45 | -3.73 | -5.06 |
RAT
WYLDF
BGEM
IGEX
BUFT
FUST